BetterLife Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:BETR.F Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
23 Jun 26	BuyUS$11,000	Ahmad Doroudian	Individual	200,000	US$0.06
05 Jun 26	BuyUS$2,241	Stephen Sangha	Individual	52,000	US$0.043
04 Jun 26	BuyUS$9,884	Stephen Sangha	Individual	229,000	US$0.043
01 Jun 26	BuyUS$10,498	Stephen Sangha	Individual	242,000	US$0.043
29 May 26	BuyUS$5,484	Stephen Sangha	Individual	126,000	US$0.044
28 May 26	BuyUS$5,606	Stephen Sangha	Individual	129,000	US$0.043
27 May 26	BuyUS$14,183	Stephen Sangha	Individual	327,000	US$0.043
26 May 26	BuyUS$652	Stephen Sangha	Individual	15,000	US$0.043
25 May 26	BuyUS$173,595	Stephen Sangha	Individual	3,993,073	US$0.043
25 May 26	BuyUS$3,518	Stephen Sangha	Individual	81,000	US$0.043
25 May 26	SellUS$183,542	Stephen Sangha	Individual	4,221,880	US$0.043
07 May 26	BuyUS$12,362	Stephen Sangha	Individual	281,000	US$0.044
06 May 26	SellUS$6,136	Ralph Pullen	Individual	130,000	US$0.048
06 May 26	SellUS$2,202	Ralph Pullen	Individual	50,000	US$0.044
27 Apr 26	BuyUS$11,411	Stephen Sangha	Individual	259,000	US$0.044
24 Apr 26	BuyUS$5,525	Stephen Sangha	Individual	126,000	US$0.044
21 Apr 26	SellUS$3,150	Ralph Pullen	Individual	70,000	US$0.048
17 Apr 26	BuyUS$9,480	Stephen Sangha	Individual	216,000	US$0.044
17 Apr 26	BuyUS$7,285	Stephen Sangha	Individual	166,000	US$0.044
10 Apr 26	BuyUS$87	Stephen Sangha	Individual	2,000	US$0.043
08 Apr 26	BuyUS$4,159	Stephen Sangha	Individual	96,000	US$0.043
31 Mar 26	BuyUS$1,118	Stephen Sangha	Individual	26,000	US$0.043
09 Mar 26	BuyUS$2,918	Stephen Sangha	Individual	61,000	US$0.048
09 Mar 26	BuyUS$3,096	Ahmad Doroudian	Individual	60,000	US$0.052
26 Feb 26	BuyUS$4,386	Stephen Sangha	Individual	100,000	US$0.044
25 Feb 26	BuyUS$4,025	Stephen Sangha	Individual	93,500	US$0.044
06 Feb 26	BuyUS$4,398	Stephen Sangha	Individual	100,000	US$0.044
02 Feb 26	BuyUS$4,021	Stephen Sangha	Individual	100,000	US$0.04
29 Jan 26	BuyUS$4,063	Stephen Sangha	Individual	100,000	US$0.041
27 Jan 26	BuyUS$7,353	Stephen Sangha	Individual	200,000	US$0.037
23 Jan 26	BuyUS$7,282	Stephen Sangha	Individual	200,000	US$0.036
15 Jan 26	BuyUS$7,198	Stephen Sangha	Individual	200,000	US$0.036
09 Jan 26	BuyUS$5,769	Stephen Sangha	Individual	160,000	US$0.036
23 Dec 25	BuyUS$3,281	Stephen Sangha	Individual	100,000	US$0.033
16 Dec 25	BuyUS$688	Ahmad Doroudian	Individual	19,000	US$0.036
25 Nov 25	BuyUS$526	Ahmad Doroudian	Individual	12,000	US$0.044
20 Nov 25	BuyUS$533	Ahmad Doroudian	Individual	15,000	US$0.036
23 Oct 25	BuyUS$858	Ahmad Doroudian	Individual	20,000	US$0.043
16 Oct 25	BuyUS$854	Ahmad Doroudian	Individual	20,000	US$0.043
03 Oct 25	BuyUS$5,018	Stephen Sangha	Individual	100,000	US$0.05
01 Oct 25	BuyUS$5,017	Stephen Sangha	Individual	100,000	US$0.05
01 Oct 25	BuyUS$5,308	Andre Beaudry	Individual	100,000	US$0.054
29 Sep 25	BuyUS$5,391	Stephen Sangha	Individual	100,000	US$0.054
29 Sep 25	BuyUS$5,391	Stephen Sangha	Individual	100,000	US$0.054
25 Sep 25	BuyUS$5,385	Stephen Sangha	Individual	100,000	US$0.054
24 Sep 25	BuyUS$8,642	Stephen Sangha	Individual	150,000	US$0.058
17 Sep 25	BuyUS$1,792	Stephen Sangha	Individual	29,000	US$0.062
17 Sep 25	BuyUS$2,533	Stephen Sangha	Individual	41,000	US$0.062
15 Sep 25	BuyUS$1,170	Stephen Sangha	Individual	19,000	US$0.062
12 Sep 25	BuyUS$1,595	Stephen Sangha	Individual	26,000	US$0.061
12 Sep 25	BuyUS$3,067	Stephen Sangha	Individual	50,000	US$0.061
11 Sep 25	BuyUS$1,475	Stephen Sangha	Individual	24,000	US$0.061
27 Aug 25	BuyUS$1,844	Stephen Sangha	Individual	30,000	US$0.061
26 Aug 25	BuyUS$123	Stephen Sangha	Individual	2,000	US$0.061
22 Aug 25	BuyUS$3,072	Stephen Sangha	Individual	50,000	US$0.061
12 Aug 25	BuyUS$12,049	Stephen Sangha	Individual	186,000	US$0.065
28 Jul 25	BuyUS$656	Stephen Sangha	Individual	10,000	US$0.066
28 Jul 25	BuyUS$693	Stephen Sangha	Individual	10,000	US$0.069
22 Jul 25	BuyUS$1,320	Stephen Sangha	Individual	20,000	US$0.066
21 Jul 25	BuyUS$2,014	Stephen Sangha	Individual	29,000	US$0.069

Insider Trading Volume

Insider Buying: BETR.F insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BETR.F?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	54,179,432	33.5%
General Public	107,707,593	66.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 8 shareholders own 33.47% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
15.8%	Stephen Sangha	25,510,449	US$4.1m	8.49%	no data
10.4%	Ahmad Doroudian	16,777,190	US$2.7m	8.75%	no data
4.26%	Hooshmand Sheshbaradaran	6,892,653	US$1.1m	0%	no data
1.01%	Moira Ong	1,637,825	US$263.7k	0%	no data
0.99%	Douglas Drysdale	1,608,000	US$258.9k	0%	no data
0.61%	Hamid Doroudian	987,148	US$158.9k	0%	no data
0.36%	Wolfgang Renz	581,500	US$93.6k	0%	no data
0.11%	Ralph Pullen	184,667	US$29.7k	-57.5%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/07/20 22:01
End of Day Share Price	2026/07/20 00:00
Earnings	2026/04/30
Annual Earnings	2026/01/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BetterLife Pharma Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.